Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus
Lysocin E is a lipopeptide with antibiotic activity against methicillin-resistant Staphylococcus aureus. Here, the authors show that the antimicrobial activity of lysocin E is potentiated through interactions with host serum proteins (such as apolipoprotein A-I) and bacterial membrane components.
Guardado en:
Autores principales: | Hiroshi Hamamoto, Suresh Panthee, Atmika Paudel, Kenichi Ishii, Jyunichiro Yasukawa, Jie Su, Atsushi Miyashita, Hiroaki Itoh, Kotaro Tokumoto, Masayuki Inoue, Kazuhisa Sekimizu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0d96c9f5e974962964e3a02e7b2c23b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a high-throughput strategy for discovery of potent analogues of antibiotic lysocin E
por: Hiroaki Itoh, et al.
Publicado: (2019) -
Discovery of gramicidin A analogues with altered activities by multidimensional screening of a one-bead-one-compound library
por: Yuri Takada, et al.
Publicado: (2020) -
Novel Pathogenic Mucorales Identified Using the Silkworm Infection Model
por: Suresh Panthee, et al.
Publicado: (2021) -
A novel application of bubble-eye strain of Carassius auratus for ex vivo fish immunological studies
por: Hiroto Nakajima, et al.
Publicado: (2021) -
Role of apolipoprotein E in neurodegenerative diseases
por: Giau VV, et al.
Publicado: (2015)